Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Protein Engineering, Design & Selection : PEDS|April 10, 2010
Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasmErik Kvam, Michael R Sierks, Charles B Shoemaker, et al.
Human Molecular Genetics|August 27, 2015
Transcriptional dysregulation of inflammatory/immune pathways after active vaccination against Huntington's diseaseArlene I Ramsingh, Kevin Manley, Yinghui Rong, et al.
Substance Use & Misuse|August 17, 2017
Depressive Symptoms and Drinking Outcomes: The Mediating Role of Drinking Motives and Protective Behavioral Strategies Among College StudentsMargo C Villarosa, Mary Anne Messer, Michael B Madson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2003
DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotypeTodd W Miller, Thomas L Shirley, William J Wolfgang, et al.
Brain Research|May 27, 2006
Molecular characterization of the genetic lesion in Dystonia musculorum (dt-Alb) miceDmitry Goryunov, Adijat Adebola, Julius J Jefferson, et al.
Plos One|November 9, 2016
Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In SituDavid C Butler, Shubhada N Joshi, Erwin De Genst, et al.
NPJ Parkinson'S Disease|August 30, 2018
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease modelDiptaman Chatterjee, Mansi Bhatt, David Butler, et al.
Biochemistry|March 10, 2004
Inhibiting aggregation of alpha-synuclein with human single chain antibody fragmentsSharareh Emadi, Ruitian Liu, Bin Yuan, et al.
Gene Therapy|March 23, 2021
Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9Diptaman Chatterjee, David J Marmion, Jodi L McBride, et al.
Pageof 5